What is the equity of Autobacs Seven Co this year?
Autobacs Seven Co has equity of 128.85 B JPY this year.
In 2024, Autobacs Seven Co's equity was 128.85 B JPY, a 5.14% increase from the 122.55 B JPY equity in the previous year.
Autobacs Seven Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Autobacs Seven Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Autobacs Seven Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Autobacs Seven Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Autobacs Seven Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Autobacs Seven Co has equity of 128.85 B JPY this year.
The equity of Autobacs Seven Co has increased/decreased by 5.14% increased compared to the previous year.
A high equity is advantageous for investors of Autobacs Seven Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Autobacs Seven Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Autobacs Seven Co can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Autobacs Seven Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Autobacs Seven Co include profits, dividend payments, capital increases, and acquisitions.
The equity of Autobacs Seven Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Autobacs Seven Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Autobacs Seven Co paid a dividend of 60 JPY . This corresponds to a dividend yield of about 4.22 %. For the coming 12 months, Autobacs Seven Co is expected to pay a dividend of 60.81 JPY.
The current dividend yield of Autobacs Seven Co is 4.22 %.
Autobacs Seven Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
Autobacs Seven Co paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 60.81 JPY are expected. This corresponds to a dividend yield of 4.28 %.
Autobacs Seven Co is assigned to the 'Cyclical consumption' sector.
To receive the latest dividend of Autobacs Seven Co from 12/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, Autobacs Seven Co distributed 60 JPY as dividends.
The dividends of Autobacs Seven Co are distributed in JPY.
Our stock analysis for Autobacs Seven Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Autobacs Seven Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.